****JavaScript based drop down DHTML menu generated by NavStudio. (OpenCube Inc. - https://www.opencube.com)****
|
|
|
|
| |
 |
 |
 |
|
|
Recent Successes
- Article about Jasper appears in MiBiz, July 25, 2005 issue *. View article.
- QTc assessment in EM / PM cohorts
- Pivotal BE study
- Dosage-form comparison study with primary biomarker endpoint
- FDA pre-IND meeting preparation
- Phase IIa / PoC program assessments, study design, and biomarker review
- Strategic organizational input
- Jasper-funded TA-based biomarker study
- Two Radiolabel studies with total recoveries >/= 95%
|
|
|
| |
 |
 |
 |
| |
| |
Company Info ||
Clinical Services ||
Consulting Services ||
Volunteer for a Study ||
Home
|
| |
| |
* COPYRIGHT 2004. MIBIZ NETWORK. ALL RIGHTS RESERVED. This article appeared in the July 25, 2005 issue of MiBiz, read by upper management executives in West and Southwest Michigan. Print subscriptions are free to qualified individuals who do business in West and Southwest Michigan. For further information about MiBiz Network, visit www.mibiz.com.
|
| |
| |
Copyright © 2004 - 2006, Jasper Clinical Research & Development Inc :: Terms of Use :: Privacy Policy
Send email to our webmaster with questions or comments about this website.
|
